These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19096817)

  • 41. Impaired cortisol binding to glucocorticoid receptors in hypertensive patients.
    Mulatero P; Panarelli M; Schiavone D; Rossi A; Mengozzi G; Kenyon CJ; Chiandussi L; Veglio F
    Hypertension; 1997 Nov; 30(5):1274-8. PubMed ID: 9369287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrolyte metabolism and the condition of glucocorticoid and mineralocorticoid functions of the adrenal cortex in different forms of Itsenko-Cushing's syndrome].
    Vasiukova EA; Granovskaia AM; Kasatkin IuN; Ryzhikov VD; Avramenko MM
    Klin Med (Mosk); 1975 Mar; 53(3):109-12. PubMed ID: 1117666
    [No Abstract]   [Full Text] [Related]  

  • 43. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.
    Walker BR; Connacher AA; Webb DJ; Edwards CR
    Clin Sci (Lond); 1992 Aug; 83(2):171-8. PubMed ID: 1327632
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cushing's syndrome: update on signs, symptoms and biochemical screening.
    Nieman LK
    Eur J Endocrinol; 2015 Oct; 173(4):M33-8. PubMed ID: 26156970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome.
    Escoté X; Aranda GB; Mora M; Casals G; Enseñat J; Vidal O; Esteban Y; Halperin I; Hanzu FA
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):26-33. PubMed ID: 28440767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic insights into Cushing syndrome.
    Assié G
    Ann Endocrinol (Paris); 2018 Jun; 79(3):119-122. PubMed ID: 29735160
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of aldosterone receptors in hypertension.
    Armanini D; Zennaro CM; Martella L; Pratesi C; Scali M; Zampollo V
    Steroids; 1993 Dec; 58(12):611-3. PubMed ID: 8116017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
    Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
    J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P
    Biochim Biophys Acta; 2010 Dec; 1802(12):1178-87. PubMed ID: 19909806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathogenesis of hypertension in Cushing's syndrome.
    Krakoff L; Nicolis G; Amsel B
    Am J Med; 1975 Feb; 58(2):216-20. PubMed ID: 1115068
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucocorticoids and gut bacteria: "The GALF Hypothesis" in the metagenomic era.
    Morris DJ; Ridlon JM
    Steroids; 2017 Sep; 125():1-13. PubMed ID: 28624548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
    Tauchmanovà L; Pivonello R; De Martino MC; Rusciano A; De Leo M; Ruosi C; Mainolfi C; Lombardi G; Salvatore M; Colao A
    Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucocorticoid action and the clinical features of Cushing's syndrome.
    Yanovski JA; Cutler GB
    Endocrinol Metab Clin North Am; 1994 Sep; 23(3):487-509. PubMed ID: 7805650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome.
    Paes T; Feelders RA; Hofland LJ
    J Clin Endocrinol Metab; 2024 May; 109(6):e1424-e1433. PubMed ID: 38517306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Undetectable urinary free cortisol concentrations in a case of Cushing's disease.
    Issa BG; Page MD; Read G; John R; Douglas-Jones A; Scanlon MF
    Eur J Endocrinol; 1999 Feb; 140(2):148-51. PubMed ID: 10069659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spontaneous hypercortisolism without Cushing's syndrome.
    Vingerhoeds AC; Thijssen JH; Schwarz F
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1128-33. PubMed ID: 186477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Steroid hormone level in patients with Itsenko-Cushing disease].
    Bezverkhaia TP; Komissarenko IV; Verkhogliadova LM; Erofeeva EN; Savitskaia VV
    Probl Endokrinol (Mosk); 1985; 31(4):17-20. PubMed ID: 4048090
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucocorticoids and cardiovascular disease.
    Walker BR
    Eur J Endocrinol; 2007 Nov; 157(5):545-59. PubMed ID: 17984234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis of Cushing's Syndrome in the Modern Era.
    Nieman LK
    Endocrinol Metab Clin North Am; 2018 Jun; 47(2):259-273. PubMed ID: 29754631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.